EG330689 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is an HDAC inhibitor that impacts histone acetylation, potentially influencing Gm5116 expression by altering chromatin structure and accessibility, thus regulating its involvement in cellular processes. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $112.00 $163.00 $928.00 | 19 | |
Trametinib, a MEK inhibitor, affects the MAPK pathway, indirectly influencing Gm5116 through this pathway, suggesting roles in cellular responses to growth signals and extracellular stimuli. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin, a PI3K inhibitor, impacts the PI3K/Akt pathway, indirectly influencing Gm5116 and hinting at its involvement in cell survival, growth, and metabolic regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580, a p38 MAPK inhibitor, affects the MAPK pathway, indirectly influencing Gm5116 and suggesting roles in cellular responses to stress, inflammation, and growth signals governed by the MAPK pathway. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 is a BET protein inhibitor affecting gene expression. It modulates the expression of genes associated with cellular processes, potentially influencing Gm5116 and revealing its involvement in transcriptional regulation and epigenetic control. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
SP600125, a JNK inhibitor, affects the MAPK pathway. By targeting JNK, it indirectly influences Gm5116 through the MAPK pathway, suggesting roles in cellular responses to stress, inflammation, and growth signals mediated by JNK signaling. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Bay 11-7082, an NF-κB inhibitor, impacts inflammatory signaling. It indirectly influences Gm5116 through the NF-κB pathway, indicating potential roles in inflammatory responses and immune regulation governed by the NF-κB signaling pathway. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $178.00 $325.00 | 67 | |
MK-2206, an Akt inhibitor, affects the PI3K/Akt pathway. By inhibiting Akt, it indirectly influences Gm5116 through the PI3K/Akt pathway, suggesting roles in cell survival, growth, and metabolic regulation in response to various stimuli regulated by Akt signaling. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $127.00 $192.00 $269.00 $502.00 $717.00 $1380.00 $2050.00 | 114 | |
Stattic, a STAT inhibitor, affects JAK/STAT signaling. By targeting STAT, it indirectly influences Gm5116 through the JAK/STAT pathway, suggesting involvement in cellular responses to cytokines and growth factors regulated by JAK/STAT signaling. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine, a DNA methyltransferase inhibitor, impacts DNA methylation. It epigenetically regulates Gm5116 expression by altering DNA methylation patterns, hinting at its involvement in transcriptional regulation and suggesting a role in epigenetic control of gene expression. | ||||||